Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
RNRenalytix Plc logo

Renalytix Plc (RNLX)

NASDAQ Global Market · Currency in USD
$0.21 ▲ +0.01 (+5.66%)
At close: Oct 7, 4:00 PM ET. Market closed.

Summary

Previous Close
$0.20
Open
$0.21
Day's Range
$0.19 – $0.23
52 Week Range
$0.18 – $2.40
Volume
726,332
Avg. Volume
785,509
Market Cap
$22.55M
Beta (5Y Monthly)
2.10
PE Ratio (TTM)
--
EPS (TTM)
-$0.62
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$2.00

Profile: Renalytix Plc

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Full-time employees
102
CEO
James R. McCullough

Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc until its name change in June 2021, focuses on creating artificial intelligence-driven in vitro diagnostic tools for kidney ailments. Its primary product, KidneyIntelX, is an advanced diagnostic system that utilizes an AI-powered algorithm. This algorithm integrates multiple data sources, including scientifically validated blood markers, genetic predispositions, and individual patient information from electronic health records, to produce a distinct risk score for kidney disease.

Earnings

DateEst.Actual
Nov 12, 2024-$0.03-$0.08Miss
Sep 30, 2024-$0.05-$0.04Beat
May 15, 2024-$0.07-$0.08Miss
Feb 14, 2024-$0.09-$0.09Beat
Nov 14, 2023-$0.11-$0.11Beat
Sep 28, 2023-$0.13-$0.10Beat

Analyst view

Consensus price target
$2.00 ▲ +865.7%
Range $2.00 – $2.00
Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Get free alerts on RNLX and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.